These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35220238)

  • 1. sIL-2R- an Immuno-biomarker for Prediction of Metastases in Uveal Melanoma.
    Barak V; Kalickman I; Pe'er J
    Anticancer Res; 2022 Mar; 42(3):1447-1453. PubMed ID: 35220238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGF as a biomarker for metastatic uveal melanoma in humans.
    Barak V; Pe'er J; Kalickman I; Frenkel S
    Curr Eye Res; 2011 Apr; 36(4):386-90. PubMed ID: 21284506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-1 as a predictive biomarker for metastatic uveal melanoma in humans.
    Frenkel S; Zloto O; Pe'er J; Barak V
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):490-3. PubMed ID: 23197685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study.
    Kadkol SS; Lin AY; Barak V; Kalickman I; Leach L; Valyi-Nagy K; Majumdar D; Setty S; Maniotis AJ; Folberg R; Pe'er J
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):802-6. PubMed ID: 16505010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in liver function tests: a comparison with serum tumor markers in metastatic uveal melanoma (part 2).
    Hendler K; Pe'er J; Kaiserman I; Baruch R; Kalickman I; Barak V; Frenkel S
    Anticancer Res; 2011 Jan; 31(1):351-7. PubMed ID: 21273623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited value of 18F-FDG PET/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma.
    Strobel K; Bode B; Dummer R; Veit-Haibach P; Fischer DR; Imhof L; Goldinger S; Steinert HC; von Schulthess GK
    Eur J Nucl Med Mol Imaging; 2009 Nov; 36(11):1774-82. PubMed ID: 19495748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum adhesion molecules and interleukin-2 receptor as markers of tumour load and prognosis in advanced cutaneous melanoma.
    Vuoristo MS; Laine S; Huhtala H; Parvinen LM; Hahka-Kemppinen M; Korpela M; Kumpulainen E; Kellokumpu-Lehtinen P
    Eur J Cancer; 2001 Sep; 37(13):1629-34. PubMed ID: 11527688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum markers to detect metastatic uveal melanoma.
    Barak V; Frenkel S; Kalickman I; Maniotis AJ; Folberg R; Pe'er J
    Anticancer Res; 2007; 27(4A):1897-900. PubMed ID: 17649791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum-soluble IL-2 receptor and IL-6 levels in patients with melanoma.
    Boyano MD; García-Vázquez MD; Gardeazabal J; García de Galdeano A; Smith-Zubiaga I; Cañavate ML; Raton JA; Bilbao I; Díaz-Pérez JL
    Oncology; 1997; 54(5):400-6. PubMed ID: 9260602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S-100B protein and melanoma inhibitory activity protein in uveal melanoma screening. A comparison with liver function tests.
    Missotten GS; Korse CM; van Dehn C; Linders TC; Keunen JE; Jager MJ; Bonfrer JM
    Tumour Biol; 2007; 28(2):63-9. PubMed ID: 17264538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric Antigen Receptor T Cell with an Inducible Caspase-9 Suicide Gene Eradicates Uveal Melanoma Liver Metastases via B7-H3 Targeting.
    Ventin M; Cattaneo G; Arya S; Jia J; Gelmi MC; Sun Y; Maggs L; Ksander BR; Verdijk RM; Boland GM; Jenkins RW; Haq R; Jager MJ; Wang X; Ryeom S; Ferrone CR
    Clin Cancer Res; 2024 Aug; 30(15):3243-3258. PubMed ID: 38767611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma.
    Boyano MD; Garcia-Vázquez MD; López-Michelena T; Gardeazabal J; Bilbao J; Cañavate ML; Galdeano AG; Izu R; Díaz-Ramón L; Raton JA; Díaz-Pérez JL
    Br J Cancer; 2000 Oct; 83(7):847-52. PubMed ID: 10970683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble interleukin-2 receptor in stage I-III melanoma.
    Ottaiano A; Leonardi E; Simeone E; Ascierto PA; Scala S; Calemma R; Bryce J; Caracò C; Satriano RA; Gianfranco N; Franco R; Botti G; Castello G
    Cytokine; 2006 Feb; 33(3):150-5. PubMed ID: 16517174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GDF-15: a novel serum marker for metastases in uveal melanoma patients.
    Suesskind D; Schatz A; Schnichels S; Coupland SE; Lake SL; Wissinger B; Bartz-Schmidt KU; Henke-Fahle S
    Graefes Arch Clin Exp Ophthalmol; 2012 Jun; 250(6):887-95. PubMed ID: 21881845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dynamics of serum tumor markers in predicting metastatic uveal melanoma (part 1).
    Barak V; Kaiserman I; Frenkel S; Hendler K; Kalickman I; Pe'er J
    Anticancer Res; 2011 Jan; 31(1):345-9. PubMed ID: 21273622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical significance of serum soluble interleukin 2 receptor (sIL-2R) concentration in lung cancer.
    Naumnik W; Chyczewska E
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():185-6. PubMed ID: 11820599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DJ-1: a promising marker in metastatic uveal melanoma.
    Chen LL; Tian JJ; Su L; Jing Y; Zhang SC; Zhang HX; Wang XQ; Zhu CB
    J Cancer Res Clin Oncol; 2015 Feb; 141(2):315-21. PubMed ID: 25129821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ME20-S as a Potential Biomarker for the Evaluation of Uveal Melanoma.
    Bande MF; Santiago M; Mera P; Piulats JM; Blanco MJ; Rodríguez-Álvarez MX; Capeans C; Piñeiro A; Pardo M
    Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7007-11. PubMed ID: 26523384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using the direct-injection model of early uveal melanoma hepatic metastasis to identify TPS as a potentially useful serum biomarker.
    Barak V; Frenkel S; Valyi-Nagy K; Leach L; Apushkin MA; Lin AY; Kalickman I; Baumann NA; Pe'er J; Maniotis AJ; Folberg R
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4399-402. PubMed ID: 17898257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Diagnostic and Prognostic Value of sIL-2R as an Immune Biomarker in Head and Neck Cancers.
    Gross M; Meirovich A; Rachmut J; Kalichman I; Peretz T; Eliashar R; Barak V
    Anticancer Res; 2016 Aug; 36(8):4347-52. PubMed ID: 27466555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.